// App-Quantinova.ai

3523 : Salvage surgery with abdominoperineal excision of the rectum (APER) following loco-regional failure after chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) and the impact on long-term outcomes: Results of ACT II.

Researchers

Presenter

  • Robert Glynne-Jones

Principal Investigators

  • Helen Margaret Meadows

  • Andre Lopes

  • Richard A. Adams

  • Leslie M. Samuel

  • James Hill

  • Andrew Renehan

  • Maria A Hawkins

  • David Sebag-Montefiore

Medical Centers

  • Mount Vernon Cancer Centre, Middlesex, United Kingdom

  • Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom

  • Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom

  • Velindre Hospital NHS Foundation Trust, Cardiff, United Kingdom

  • Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • University of Leeds and Leeds Cancer Centre, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anal squamous cell carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • mitomycin

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved